Cardiovascular risk reduction: What really works?

Patient Care

Volumn 31, Issue 10, 1997, Pages 47-60

  Hoff, Gary L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007377385     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Preliminary data on births and deaths - United States, 1995. MMWR 1996;45:914-919.
2. Multiple Risk Factor Intervention Trial Research Group: Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation 1996;94:946-951.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel II). JAMA 1993;269:3015-3023.
4. Manson JE, Tosteson H, Ridker PM, et al: The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406-1416.
5. Friedman M, Breall WS, Goodwin ML, et al: Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in coronary patients. Am Heart J 1996;132:933-937.
6. Barefoot JC, Schroll M: Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-1980.
7. Milani RV, Lavie CJ, Cassidy MM: Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996;132:726-732.
8. Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333: 1301-1307.
9. Scandinavian Simvastatin Survival Study: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
10. Pedersen TR, Kjekshus J, Berg K, et al: Cholesterol lowering and the use of healthcare resources: Results of the Scandinavian Simvastatin Survival Study. Circulation 1996;93:1796-1802.
11. Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009.
12. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
13. Roberts WC: Preventing and arresting coronary atherosclerosis. Am Heart J 1995;130:580-600.
14. Kannel WB: Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 1996;275:1571-1576.
15. Jones PH, Gotto AM Jr: Prevention of coronary heart disease in 1994: Evidence for intervention. Heart Dis Stroke 1994;3:290-296.
16. Meigs JB, Singer DE, Sullivan LM, et at: Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcomes Research Team. Am J Med 1997;102:38-47.
17. Ockene JK, Kristeller J, Goldberg R, et al: Increasing the efficacy of physician-delivered smoking interventions: A randomized clinical trial. J Gen Intern Med 1991;6:1-8.
18. Ockene JK, Ockene IS, Quirk ME, et al: Physician training for patient-centered nutrition counseling in a lipid intervention trial. Prev Med 1995;24:563-570.
19. Amsterdam EA, Hyson D, Kappagoda CT. Nonpharmacologic therapy for coronary artery atherosclerosis: Results of primary and secondary prevention trials. Am Heart J 1994;128:1344-1352.
20. Joseph AM, Norman SM, Ferry LH, et al: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-1798.
21. Morrison HI, Schaubel D, Desmeules M, et al: Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-1896.